M Kawsar1, B T Goh. 1. Ambrose King Centre, The Royal London Hospital, UK. mo.kawsar@hotmail.com
Abstract
OBJECTIVE: To determine prevalence of hepatitis B virus (HBV) serological markers in Chinese residents in the United Kingdom. METHOD: Retrospective case-controlled study between January 1997 and June 2000 in two genitourinary medicine (GUM) clinics. RESULTS: 117 Chinese and 234 non-Chinese controls were studied. Baseline characteristics except marital status showed no difference. Overall prevalence of HBV serological markers was 35.8% in Chinese, controls 5.5% (p<0.001). Hepatitis B surface antigen (HBsAg) positive carrier rate was 12.8% in Chinese, controls 0.4% (p<0.001); 1.7% of Chinese patients were also hepatitis B e antigen (HBeAg) positive, none in controls. Natural immunity was acquired in 23.0% of Chinese, controls 5.1% (p<0.001). Prevalence of HBV serological markers in UK born Chinese was 6.7%, non-UK born Chinese 40.1% (p<0.011). Only 7.6% of Chinese had a history of previous HBV vaccination. CONCLUSIONS: Prevalence of HBV serological markers among Chinese patients attending two GUM clinics in London was high and only a minority of Chinese had immunisation against HBV. Although the prevalence of HBV markers in UK born Chinese was lower than non-UK born Chinese, they may be at continuous risk of HBV infection. Non-UK born Chinese patients attending GUM services in the United Kingdom should be targeted for screening and vaccination to reduce HBV transmission.
OBJECTIVE: To determine prevalence of hepatitis B virus (HBV) serological markers in Chinese residents in the United Kingdom. METHOD: Retrospective case-controlled study between January 1997 and June 2000 in two genitourinary medicine (GUM) clinics. RESULTS: 117 Chinese and 234 non-Chinese controls were studied. Baseline characteristics except marital status showed no difference. Overall prevalence of HBV serological markers was 35.8% in Chinese, controls 5.5% (p<0.001). Hepatitis B surface antigen (HBsAg) positive carrier rate was 12.8% in Chinese, controls 0.4% (p<0.001); 1.7% of Chinese patients were also hepatitis B e antigen (HBeAg) positive, none in controls. Natural immunity was acquired in 23.0% of Chinese, controls 5.1% (p<0.001). Prevalence of HBV serological markers in UK born Chinese was 6.7%, non-UK born Chinese 40.1% (p<0.011). Only 7.6% of Chinese had a history of previous HBV vaccination. CONCLUSIONS: Prevalence of HBV serological markers among Chinese patients attending two GUM clinics in London was high and only a minority of Chinese had immunisation against HBV. Although the prevalence of HBV markers in UK born Chinese was lower than non-UK born Chinese, they may be at continuous risk of HBV infection. Non-UK born Chinese patients attending GUM services in the United Kingdom should be targeted for screening and vaccination to reduce HBV transmission.
Authors: Y F Liaw; N W Leung; T T Chang; R Guan; D I Tai; K Y Ng; R N Chien; J Dent; L Roman; S Edmundson; C L Lai Journal: Gastroenterology Date: 2000-07 Impact factor: 22.682
Authors: Andrew Chee Keng Lee; Alicia Vedio; Eva Zhi Hong Liu; Jason Horsley; Amrita Jesurasa; Sarah Salway Journal: BMC Public Health Date: 2017-09-26 Impact factor: 3.295
Authors: Natasha K Martin; Peter Vickerman; Salim Khakoo; Anjan Ghosh; Mary Ramsay; M Hickman; Jack Williams; Alec Miners Journal: BMJ Open Date: 2019-06-28 Impact factor: 2.692
Authors: Iro Evlampidou; Matthew Hickman; Charles Irish; Nick Young; Isabel Oliver; Sophie Gillett; Alexandra Cochrane Journal: Br J Gen Pract Date: 2016-03-29 Impact factor: 5.386
Authors: M A Balogun; J V Parry; K Mutton; C Okolo; L Benons; H Baxendale; T Hardiman; E H Boxall; J Sira; M Brown; S Barnett; U Gungabissoon; A Williams; D A Kelly; S Vijeratnam; S Ijaz; B Taylor; C G Teo; M E Ramsay Journal: Epidemiol Infect Date: 2012-07-31 Impact factor: 4.434